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ABSTRACT 
  
             This study aimed at assessing the occurrence of chicken 
anemia virus (CAV) in Khartoum state. (Sudan) in an attempt to 
determine prevalence of the disease in state. It was carried out 
using indirect ELISA commercial kit. Serum samples were 
collected from different commercial chicken farms in different 
areas in Khartoum State. prevalence of antibodies against CAV in 
sera collected from these farms was determined from a total of 450 
serum samples (350 commercial layers, 75 broilers and 35 
breeder layers). Out of the total serum samples 397 (88.2%) were 
positive. Out of 350 serum samples from layers 311 (91.5%) were 
positive. In broiler flocks, 52 (69.3%) were positive. Evaluation of 
breeder layers showed 34 (97.1%) positive results. Prevalence of 
antibodies against CAV was determined in different age groups of 
chicken flocks ranged from day on to 102 wks did. No age 
variation in the disease distribution was noted clinical sings found 
were, hemorrhagic dermatitis, dullness and pale comb and wattles. 
Post mortem examination for positively diagnosed cases showed 
enlarged pale liver. Congested viscera and subcutaneous 
hemorrhage.  
In conclusion, the disease is highly prevalent in Khartoum State as 
determined by the serosurvey using an indirect ELISA.  
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 اﻟﻤﺴﺘﺨﻠﺺ 
  
اﻟﺪﺟﺎج ﻓﻲ وﻻﻳﺔ اﻟﺨﺮﻃﻮم ﺑﺎﻟﺴﻮدان ﻓﻲ هﺪﻓﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﺘﺤﺪﻳﺪ وﺟﻮد ﻓﻴﺮوس اﻧﻴﻤﻴﺎ 
ﺗﻤﺖ هﺬﻩ اﻟﺪراﺳﺔ ﺑﺎﺳﺘﻌﻤﺎل ﻣﻘﺎﻳﺴﺔ اﻹﻟﻴﺰا .  ﻟﻤﻌﺮﻓﺔ ﻧﺴﺒﺔ اﻹﺻﺎﺑﺔ ﺑﺎﻟﻤﺮض ﻓﻲ اﻟﻮﻻﻳﺔﻣﺤﺎوﻟﺔ
ﺟﻤﻌﺖ ﻋﻴﻨﺎت اﻟﻤﺼﻞ ﻣﻦ ﺧﻼل اﻟﺘﻘﺼﻲ اﻟﺤﻘﻠﻲ ﻟﻤﺨﺘﻠﻒ ﻣﺰارع (. اﻟﻄﻘﻢ اﻟﺠﺎهﺰ)ﻏﻴﺮ اﻟﻤﺒﺎﺷﺮة 
 043) ﻋﻴﻨﺔ ﻣﺼﻞ 054اﻟﺪواﺟﻦ اﻟﺘﺠﺎرﻳﺔ ﺑﻮﻻﻳﺔ اﻟﺨﺮﻃﻮم ﻟﻘﻴﺎس ﻧﺴﺒﺔ اﻷﺟﺴﺎم اﻟﻤﻀﺎدة ﻓﻲ 
%( 2.88 )793ﻣﻦ اﻟﻤﺠﻤﻮع اﻟﻜﻠﻲ ﻟﻸﻣﺼﺎل، (.  أﻣﻬﺎت53 دﺟﺎج ﻻﺣﻢ و 57دﺟﺎﺟﺔ ﺑﻴﺎﺿﺔ، 
  . آﺎﻧﺖ ﻣﻮﺟﺒﺔ
أﻣﺎ . آﺎﻧﺖ ﻣﻮﺟﺒﺔ%( 5.19 )113 ﻋﻴﻨﺔ ﻣﺼﻞ أﺧﺬت ﻣﻦ اﻟﺪﺟﺎج اﻟﺒﻴﺎض، 043ﻣﻦ 
أوﺿﺢ اﻟﻜﺸﻒ ﻋﻦ أﻣﻬﺎت %(. 3.96) ﺑﻨﺴﺒﺔ 25ﻓﻲ اﻟﺪﺟﺎج اﻟﻼﺣﻢ ﻓﻘﺪ آﺎﻧﺖ اﻷﻣﺼﺎل اﻟﻤﻮﺟﺒﺔ 
ﺗﻢ ﺗﺤﺪﻳﺪﻧﺴﺒﺔ اﻧﺘﺸﺎر ﻓﻴﺮوس اﻧﻴﻤﻴﺎ اﻟﺪﺟﺎج ﻓﻲ %(. 1.79 ) ﻋﻴﻨﺔ آﺎﻧﺖ إﻳﺠﺎﺑﻴﺔ43اﻟﺒﻴﺎض أن 
ﻟﻢ ﺗﻮﺟﺪ اﺧﺘﻼﻓﺎت ﻓﻲ ﻧﺴﺒﺔ ﺗﻮزﻳﻊ .  اﺳﺒﻮع201ﻣﺨﺘﻠﻒ اﻷﻋﻤﺎر ﻣﻦ ﻋﻤﺮ ﻳﻮم ﺣﺘﻰ ﻋﻤﺮ 
هﺰال، اﻟﺘﻬﺎب ﺟﻠﺪ : اﻷﻋﺮاض اﻟﺴﺮﻳﺮﻳﺔ اﻟﺘﻰ وﺟﺪت. اﻟﻤﺮض ﻓﻲ اﻷﻋﻤﺎر اﻟﻤﺨﺘﻠﻔﺔ ﻟﻠﺪواﺟﻦ
 ﻓﻲ اﻟﺤﺎﻻت اﻟﺘﻰ أﻇﻬﺮت ﻧﺘﻴﺠﺔ ﻣﻮﺟﺒﺔ اﻵﻓﺎت اﻟﺘﺸﺮﻳﺤﻴﺔ. ﻧﺰﻓﻲ وﺷﺤﻮب ﻓﻲ اﻟﻌﺮف واﻟﺪﻻﻳﺘﻴﻦ
ﻋﻨﺪ اﻟﻜﺸﻒ ﻋﻦ اﻟﻤﺼﻞ أﺑﺎﻧﺖ ﺷﺤﻮب وﺗﻀﺨﻢ ﻓﻲ اﻟﻜﺒﺪ ، اﺣﺘﻘﺎن ﻓﻲ اﻷﺣﺸﺎء اﻟﺪاﺧﻠﻴﺔ وﻧﺰﻳﻒ 
  . ﺗﺤﺖ اﻟﺠﻠﺪ
ﺧﻼﺻﺔ هﺬﻩ اﻟﺪراﺳﺔ ﺗﺸﻴﺮ إﻟﻲ أن اﻟﻤﺮض ﻣﻨﺘﺸﺮ ﺑﻨﺴﺒﺔ ﻋﺎﻟﻴﺔ ﻓﻲ وﻻﻳﺔ اﻟﺨﺮﻃﻮم آﻤﺎ 
  . ﺘﺒﺎر اﻹﻟﻴﺰا ﻏﻴﺮ اﻟﻤﺒﺎﺷﺮﺗﺒﻴﻦ ﻣﻦ ﻗﻴﺎس ﻧﺴﺒﺔ اﻷﺟﺴﺎم اﻟﻤﻀﺎدة ﻓﻲ اﻷﻣﺼﺎل ﺑﻮاﺳﻄﺔ اﺧ
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INTRODUCTION 
             The poultry industry has been one of the most dynamic and ever 
expanding   sectors in the world during the last two decade. It helps to bridge 
the gap between requirements and availability of high quality protein for 
human consumption, so the demand for a higher quality protein source free of 
infectious agent is getting increased. The major economic losses for the 
poultry industry in the form of mortality, production losses,  condemnation and 
the cost of preventive medication are due to infectious diseases which caused 
by viruses, bacteria, fungi and parasites.  One of these infectious diseases is 
chicken infectious anemia (CIA). Which is an immunosuppressive disease 
primarily  of young chicken, but can affect all ages. It causes high mortality 
and reduced performance by making birds more susceptible to secondary 
infections. The clinical disease is mainly noticed in young chicks of 10-14 days 
of ages, which usually acquires the infection vertically, The disease is 
characterized by increased mortality, reduced weight gain, a plastic anemia, a 
plasia of bone marrow and atrophy of thymus. The disease is of worldwide 
distribution and typical characteristics made it an economically important 
avian pathogen. 
         The chicken anemia virus (CAV) was first described in 1979 by Yuasa   
and co-workers in Japan in commercially produced chickens, since that time 
the virus has been detected by isolation or serology in most other countries in 
both laying and broiler chickens (Bulow and Schat, 1997).  
      The disease is frequently complicated by secondary viral, bacterial or 
fungal infections. CIA related syndromes are commonly known as 
hemorrhagic Syndrome, infectious aplastic anemia, anemia dermatitis or blue 
wing disease (Pope, 1991). The disease also poses serious threats to broiler 
industry and producer of SPF eggs.  
          The  CAV, belonging to genus Gyrovirus, of the family, Circovirridae. It 
is the smallest avian virus with circular single stranded genome, the virus is 
highly contagious and can be   transmitted  both horizontal and vertical. 
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            Chicken is the only recognized natural host, but serological survey has 
revealed the prevalence of the disease in other domestic and wild birds 
(Farkas et al., 1998).  
           The diagnosis of the disease based on clinical signs and needs to be 
confirmed by subsequent laboratory tests.  
           Antibody testing for CAV is an essential part of monitoring the chicken 
flocks for the presence of the virus, however, a link may exist between the 
genetic background of chicken strain and the development of humoral 
Immune responses to CAV and also between the virus strains and host 
immunosuppressivness  (Cardona  et al., 2000a). 
           Previous observations reported that chicken infected at older ages with 
CAV showed seroconversion already after 4—7 days where as in chicks 
infected at day one antibodies can be detected only after 2—3 weeks (Hoop 
and Reece, 1991). 
           The goal of this study is to assess the occurance of CAV in Khartoum 
state and determine the prevalence of the disease in the state since it is an 
important emerging avian pathogen and one of the immunosuppressive 
diseases that affects chickens at early ages and leads to high mortality and 
lower production in surviving chicks.    
 
 
 
 
 
 
 
 
3 
 
 Objectives   
1. To study the incidence of CAV in Khartoum state. 
2. To investigate the prevalence of antibodies in susceptible chickens with 
different types, ages and breed. 
3. To evaluate the prevalence of the disease in order to advice a control 
measurements   that must be followed, such as vaccination to reduce 
incidence of the disease in Khartoum state.  
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CHAPTER ONE 
REVIEW OF THE LITERATURE 
             Chicken infectious anemia (CIA), is an emerging disease mainly of 
young chicken characterized by poor weight gain, severe anemia, aplasia of 
bone marrow and subcutaneous and muscular hemorrhage.    
           Increased mortality of the disease has been responsible for 
considerable health problems and economic losses to the poultry industry 
(McNulty et al., 1991; Bulow and S chat, 1997; Hagood et al., 2000). The CAV 
was first described by Yuasa et al., 1979 and classified in new established 
genus Gyrovirus under the family Circovirridae (Pringle, 1991).    
       The first report of CAV isolation in the U.S was by Rosenberger and 
Cloud (1989a). Based on retrospective serological and  clinical  evaluation 
that the virus has existed in the U.S for at least 25 years.  It is now being 
recognized as an important pathogen worldwide (McNulty etal., 1991;  Farkas 
et al., 1992; Macllory et al., 1992;   Bulow and Schat 1997; Rosenberger and 
Cloud, 1998).  The disease has been proven to be a potent 
immunosuppressive agent for very young un protected chicken (Van Den 
Berg, 1996; Adair, 2000; De Herdt et al.,   2001). 
1- The virus 
1-1 Classification of the virus 
         Chicken anemia virus (CAV) is a small nonenveloped, single stranded 
DNA virus, which was classified in genus Circovirus,  family circovirridae on 
the basis of morphology and circular genome characteristics, along with two 
other single stranded DNA viruses Porcine circovirus (PCV) and Psittacine 
beak feather disease virus (PBFDV) (Studdert, 1993; Lukert et al., 1995).  
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        As CAV differ from other circoviruses in morphology, size, antigenic 
determinants and gene arrangement (Todd et al., 1991; Noteborn and Koch, 
1995), It is recently placed under new genus Gyrovirus in the Circovirridae 
family (Pringle, 1999; Todd et al., 2000). 
1-2 Morphology 
          It is very small, naked, icosahedral and negative sense DNA virus with 
spherical or hexagonal shape, measures 23—25 nanometer in diameter 
(McNulty et al., 1990a; Todd et al., 1994). It is genome is circular, 2.3 kb 
covalently closed ss DNA enclosed in a capsid of 32 capsomeres (Todd et al., 
1990; Allan et al., 1994; Bulow and Schat, 1997 ).   
1-3 Strain differentiation  
1-3-1 Antigenicity 
                No significant antigenic differences have been recognized among 
various CAV strains using polyclonal antibodies. There exists only one 
serotype of CAV worldwide (Yuasa and Imai, 1986; McNulty etal., 1990a; 
Bulow and Schat 1997; Adair, 2000).  However, monoclonal antibodies 
revealed antigenic differences based on immune florescence reaction patterns 
on staining between isolates which are indistinguishable using polyclonal anti 
sera (McNulty et al., 1990c). 
1-3-2 Molecular differences   
            Several strains from different parts of the world have been sequenced,   
minor molecular differences have been noted especially for the amino acid of 
VP1 (Noteborn et al., 1998a), and also at the carboxi terminous of VP2 and 
VP3, but the importance of hypervariable region for the pathogenicity in vivo is 
not clear (Meehan et al., 1997). 
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1-4 Physicochemical properties     
            The structure of CAV confers remarkable chemical and thermal 
stability. The virus has ability to resist inactivation by various physicochemical 
agents,exposure to  pH3,  lipid solvents  (ether or chloroform or acetone) and 
many commercial disinfectants  (Yuasa, 1992; Taylor, 1992;  Allan et al., 
1994).  
        The virus is resistant to treatment with 50% ethyl ether, chloroform for 15 
min, 0.1 Na OH for  (2hrs).  Treatment with 1% glutraldehyde  for 10 min at 
room temp,  5% formaldehyde  for 24 hrs at room temp inactivate the virus.   
Iodine and sodium hypochlorite at 1% concentration can also inactivate the 
virus (Yuasa, 1992). The virus has been shown remarkably withstand temp of 
56oC or 70oC for one hour and up to 80oC for15 min. Heating at temp of 
100oC completely inactivate the virus within 15 mins (Urlings et al., 1993). 
1-5  Viral proteins 
         Three putative viral proteins VP1 (45—52 Kda 449 AA), VP2 (24—30 
Kda 216 AA) and VP3 (13.6—16 Kda 121 AA) have been well characterized 
by several workers (Noteborn et al., 1991; Classen et al., 1991).VP1 is the 
major structural capsid protein (Todd et al., 1994; Koch et al., 1994). It is the 
only protein detected in highly purified virus particles. VP2 is none structural 
protein acting as a scaffold protein during virion assembly (Buchholz and 
Bulow, 1994). VP3 is associated with nuclei in infected cells but not with 
highly purified virus particles, but it is important for its life cycle (Noteborn et 
al., 1998).   Both VP1 and VP2 are involved with antigenicity of the virus and 
formation of neutralizing antibodies in CAV infected cells (Koch et al., 1994, 
1995; Noteborn et al., 1998a). VP3 is poorly immunogenic (Cunningham et 
al., 2001). It induces apoptosis in specific lymphoid cells, the chicken 
thymocytes  and chicken lymphoblastoids cell lines (MSBI) (Jeurissen et al., 
1992b),  which is also an important phenomenon during the pathogenesis of 
CAV (Noteborn  et al.,  1992a;  Chu et al.,  2001) .    
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1-6 Virus replication 
            Virion enters the cell by conventional adsorption and penetration, RNA 
transcription can be demonstrated at 8 hrs post infection of MSBI cells 
(Noteborn et al., 1994; Koch et al., 1995). VP3 can be detected at 6 hrs and 
VP2 present at 12 hrs post infection. The capsid protein VP1 is not detectable 
until 30 hrs post infection (Todd et al., 1994).   
              The replication of CAV in chickens occurs primarily in haemo 
cytoblast in bone marrow   and T cells precursor in the cortex of the thymus   
(Adair et al., 2000). Virus replication has also been demonstrated in other 
organs  where it is often but not always associated with lymphocytes ( Smyth 
et al., 1993).  Replication of the virus was known to result in cell death by 
apoptosis caused by VP3 (Jeurissen et al., 1992a;  Noteborn et al., 1992a).   
2- The disease  
            Chicken infectious anemia (CIA) is a highly contagiuos disease with a 
high prevalence in countries with intensive poultry production. Clinical disease 
is very uncommon since many breeders seroconvert to CAV either as a result 
of natural infection or vaccination before they come in to lay, so that progeny 
of breeder flocks are protected by maternal antibodies. Much more common 
are subclinical infections in chicks above 3 weeks of age. Out breaks of CAV 
are there for sporadic in the field (Imai and Yuasa, 1990; Bulow and Schat, 
1997; Todd, 2000).  
2-1 Epidemiology of the disease    
          Serological data had suggested that CIAV appeared to be ubiquitous in 
all major chicken producing countries of the world (Bulow and SChat, 1997).  
This is confirmed by virus isolation in Japan (yuasa  et al., 1979; Goryo  et al., 
1985; Yuasa and Imai, 1986; Otaki  et al., 1987). In China (Tang, 1994;  
Zhuang et al., 1995a).  In U.S.A (McNulty et al., 1989a; Rosenberger and 
Cloud, 1989a;   Lamichhane  et al., 1991; Goodwin et al., 1993). 
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           In South America (Brentano et al., 1991; Toro et al., 1997). In Australia 
(Firth and Imai, 1990). In New Zealand (Lawek et al., 1994). In South Africa 
(Wicht and Maharai, 1993).  In Eygypt ( Eliethi et al.,  1990;   Zaki  and  
Elsanousi,  1994;  Sabry et al., 1998; Amin et al., 1998), the molecular 
diagnosis was performed by Heussien et al.(2001) and Jordan, Dergham, 
(2006). 
2-1-1 Disease status in Sudan   
          The CAV infection in chicken flocks in the Sudan was reported for the 
first time in 2005,   through a serological survey of CIA which was carried out 
in a commercial chicken flocks in Khartoum state. Serum samples from un 
vaccinated flocks (layer, broiler and breeder) were analyzed for CAV 
antibodies with an Enzyme Linked Immune sorbent Assay (ELISA), CAV 
antibodies were detected in 62% of the samples (Ballal et al., 2005).  
2-2 Transmission 
                   Chicken anemia virus (CAV) transmitted both horizontally and 
vertically. Horizontal transmission is based on the presence of high 
concentration of the virus in feces of chickens for 5—7 weeks after infection 
(Yuasa et al., 1983; Hoop et al., 1992). Infection via oral route either direct or 
indirect but infection via respiratory route may occur after intra tracheal 
inoculation of the virus and may also be possible in the field (Rosenberger 
and cloud, 1989a).  
                 Vertical transmission in commercial flocks throughout the hatching 
egg is considered to be the most important mean for transmission (Chettle et 
al., 1989;  Engstrom et al., 1999). Vertical transmission occurs when antibody 
negative hens become infected or by semen from infected cock (Hoop and 
Reece, 1991). Another possible method of spread is through contaminated 
vaccines because the virus has been detected in some SPF flocks used for 
vaccine production.  This raises the possibility that such vaccine might have 
been responsible for disseminating CAV infection in the past (Cardona  et al., 
2000a). 
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2-3 Susceptibility                   
                 The chicken is the only known host for CAV. All ages are 
susceptible to infection, but susceptibility to disease rapidly decreases in 
immunologically intact chicks during the first 1—3 weeks of life (Yuasa and 
Imai, 1979; Yuasa; et al., 1980a; Goryo et al., 1985; Rosenberger and Cloud 
1989b). Although  some strains have been reported to cause clinical disease 
after experimental infection of 10 weeks old broiler breeders.    (Toro  et al., 
1997). Chicks are at increased risk of infection with CAV and the period of 
susceptibility to disease may be extended by an early exposure to other 
lymphocidal agents such as IBDV,  MDV,   REV,  adenovirus and other agents 
interfere with normal immune system development (Engstrom et al.,  1988 ; 
Rosenberger and Cloud,  1989b;  Bulow and Schat,  1997;  Imai et al.,  1999), 
or by  bursectomy  (Yuasa et al., 1988;  Lucio  et al., 1990;  Hu et al., 1993a). 
A connection between genetic strain of chicken and susceptibility to CAV 
infection has also been   reported (Cardona et al., 2000a).  
2-4 Incubation period  
             Incubation period  is 10—14 days under field conditions. Congenitally 
infected chicks show clinical signs and increased mortality beginning at 10—
12 days of age, with a peak at 17—24 days (Engstrom et al., 1984; Gyro et 
al., 1987a;   Chetle et al., 1989; Jorgensen, 1990). In heavily infected flocks 
there can be a second peak of mortality at 30—34 days probably due to 
horizontal transmission (Engstrom   et al., 1984; Jorgensen, 1991).         
2-5 Clinical signs  
               The only specific sign of CAV infection is anemia characterized by 
hematocrit value ranges from 6—27%. Affected birds can be depressed and 
become pale, weight gain is depressed between 10—20 days after infection, if 
mortality occurs does not exceed 30%. Surviving chicks completely recover 
from depression and anemia by 20—28 days after infection (Yuasa et al., 
1979; Taniguchi et al., 1983; Goryo et al., 1985; Bulow et al., 1986a; 
Rosenberger et al., 1989a). The disease is acute and the clinical stage induce 
inconsistent pathognomic symptoms of depression, anemia, weakness, 
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anorexia, ruffled feather and stunted growth particularly between 10—20 days 
post infection. Depending on the disease severity anemia is noticeable on the 
non-feathered areas such as the comb & wattle, eyelids and legs and finally 
the bird becomes  marked paler  that may extends to internal organs (Yuasa 
et al., 1979;  Goryo et al., 1985; Pope, 1991).     
2-6 Morbidity and mortality  
                Mortality peaks with in third week of infection and varies between 
5% &10 % up to 60% (Tainguchi et al., 1982; Engstrom and Luthman, 1984; 
McNulty et al., 1991). Morbidity similarly varies between 20—60% usually no 
more than 30%  of birds die between 12—28 days post infection and both 
may influence by the virulence , dose and route of infection of the CAV strain 
(Goryo et al.,  1985; Yuasa and Imai,  1986).  
2-7 Lesions                 
              Lesions associated with CAV may vary depending on the route of 
infection, age of exposure, viral dose and immune status of the host.  Thymus 
atrophy sometime results in complete absence of the lobes and this is the 
most consistent lesion (Goryo et al., 1985; Jeurissent et al., 1992b; Yuasa, 
1983).  Atrophy of the bursa and to a lesser extend the spleen, pale and 
enlarged liver and yellow fatty bone marrow are the most characteristic 
lesions because of anemia. Other visceral organs might show areas of 
congestion and hemorrhage (Yuasa et al., 1979; Goryo et al., 1985; Bulow 
and Schat, 1997).   
2-8 Histopathology    
               In the bone marrow atrophy and aplasia involve all components and 
hematopoietic linage.  Necrosis of residual small cells may be seen, adipose 
tissue replace hematopoietic cells, hyperplasia  of bone marrow between24—
32 days post infection can be observed. 
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             Severe lymphoid depletion in the thymus with hydropic degeneration 
of residual cells (Bulow et al., 1985,   1986a; Goryo et al., 1989a; Jeurissen et 
al., 1989; McNulty and Todd 1991).  Lesions in the bursa consist of mild to 
severe atrophy of lymphoid follicles with small necrotic foci, hydropic epithelial 
degeneration and proliferation of reticular cells. In the spleen, depletion of T 
cells, hyperplasia of reticular cells and necrotic foci and in the liver,  kidneys,  
lungs and proventriculus,  necrotic foci,  depletion of cells, dilation of hepatic 
sinusoids and small esinophilic nuclear inclusion bodies have been detected 
in altered cells of affected tissues (Goryo et al.,  1989a;  McNulty and Todd, 
1991).     
2-9 Factors affecting the disease severity 
                    Uncomplicated infectious anemia especially if caused by 
horizontal infection, result in slightly increased mortality and transient poor 
performance of affected flocks,  severity of the disease is related to the viral 
dose,  age,  maternal antibodies and route of infection (vertical or horizontal) 
(Yuasa et al., 1980;  Rosenberger and Cloud 1989b;  McNulty et al., 1990b). 
Bursal atrophy is an important risk factor for the development of CIA infection 
(Yuasa et al., 1988; Hu et al., 1993a; Hagood et al., 2000). Chemical immune 
suppression by beta methasone or Cyclosporine A also aggravates signs and 
lesions (Bulow and Rudolph, 1987).  
               Co infection with other lymphocidal agents like IBD &  MD lead to 
increased mortality which usually seen in field cases (Bulow et al., 1983;   
Engstrom et al., 1988; McNulty, 1991; Todd, 2000; Miles et al., 2001). .    
2-10 Pathogenesis  
               The basic events during the pathogenesis of CAV infection has been 
elucidated by sequential histopathology (;  Yuasa et al., 1983 Goryo et al., 
1989a; Smyth et al.  1993), and immune cytological studies (Hoop and  
Reece,  1991; Smyth et al., 1993). Hemocytoblast in the bone marrow and 
lymphoblast in the thymus cortex are primarily involved in early cytolytic 
infection at 6—8 days post infection leading to rapid depletion and apoptosis 
of these cells.           
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                 In contrast to the thymus depletion of lymphoid cells have been 
detected before10—12 days post infection, repopulation of the thymus with 
lymphocytes and recovery of hematopoietic activity from 16 day after 
inoculation, appear to be coincides with the beginning of antibody formation 
(Yuasa et al., 1983; Bulow et al., 1986b; Goryo et al., 1989a;   Smyth et al., 
1993) .Viral antigens has also been demonstrated in lymphoid tissues in other 
organs (Smyth et al., 1993). 
                   Infection of proventriculus, the ascending part of the duodenum, 
kidney and  lung could provide an explanation of virus shedding.  Infected 
cells in these tissues usually cannot be detected for more than 22 days after 
infection at one day of age (Smyth et al., 1993).  
2.11 Age resistance 
                 Age resistance develops rapidly during the first week of life and 
become complete by 3 week or even earlier in immunologically competent 
chickens. The degree of  resistance vary based on the virulence of the virus, 
dose and route of infection (Goryo et al., 1985; Yuasa and Imai, 1986; 
Rosenberger and Cloud, 1989b; Toro et al., 1997). 
                  Antibody development is considerably delayed by immune 
suppression such as simultaneous infection with IBDV (Imai et al., 1999; 
Rosenberger and Cloud, 1989b; Yuasa et al., 1980a). 
2-12 Maternal antibodies 
           Maternal antibodies to CAV confer virtually complete protection against 
the disease (Yuasa et al., 1980a; Taniguchi et al., 1982; Otaki et al., 1992).  
This protection can be abrogated if chicks are immune suppressed by other 
viral infections that affect humoral  immune response such as IBDV (Bulow et 
al., 1986a; Rosenberger and Cloud,  1989b). 
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2-13 Immunity  
2-13-1 Active immunity 
                  Antibody responses are the major arm of protective immunity to 
CIA, but neutralizing antibodies cannot be detected until 3 weeks post 
inoculation of susceptible one day old chicks. Titers are low and show little 
increase until 4 weeks (Yuasa et al., 1983; Dren et al., 2000). Yuasa et al 
(1983a) reported that increasing antibody production concides with 
decreasing virus concentration in chicken tissues. 
            Seroconversion in horizontally infected breeder flocks may be 
detected as early as 8—9 weeks of age and most flocks have antibodies to 
CAV at 18—24 week (McNulty et al., 1988:  Imai et al., 1993). High titers of 
antibodies persist in all birds of a flock for at least 52 weeks. The prevalence 
of antibodies detected by ELISA may decrease with increasing age (Imai et 
al., 1993). Antibodies detected by a commercial kit will remain present until 
60—80 week of age in CIA infected SPF flocks (Cardona et al., 2000a). 
2-13-2 Passive immunity 
                Maternal antibodies derived immunity persists for 3 weeks (McNulty 
et al., 1988; Otaki et al., 1992).  Furthermore, vertical   transmission of the 
virus is likely to occur from antibody positive hens, but viral DNA can still be 
transmitted (Cardona et al., 2000a; Miller and Schat, 2001).  
             Outbreaks of CIA in the field are in fact correlated with the absence of 
CAV antibody in the respective parent flocks (Veilitz et al., 1986; Yuasa et al., 
1987;  Chettle et al., 1989; Engstrom, 1999).  
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3- Diagnosis of CAV 
3-1 Isolation & identification of CAV  
               Virus can be isolated from most tissues, buffy coat cells and rectal 
contents from diseased chickens with maximum virus titer detected at 7 days 
after Infection (Yuasa et al., 1983a; McNulty, 1988). The virus titer will 
decreased after antibodies development , but whole blood and  buffy coat 
cells found to be infectious for at least 14 days post infection (Bulow et al.,  
1983;  Yuasa, 1994 ). Liver or lymphocytes from spleen are prefered sources 
for virus isolation.           
3-1-1 Virus isolation in cell culture  
              MPCC-CU147 or MSBI cell cultures are preferred for virus isolation 
and titration (Yuasa et al., 1983; Calnek et al., 2000). Some CIAV strains do 
not readily replicate in MSBI, and differences in susceptibility of MSBI sublines 
have been reported (Bulow et al., 1991; Rosenberger et al., 1994; Soine et 
al., 1994). 
3-1-2 Virus isolation in susceptible host    
              Intramuscular or intraperitoneal inoculation of susceptible one day old 
chicks, is the most specific method available for primary isolation of CAV. This 
approach can be used if CAV is suspected,  but virus  cannot be isolated,  it is 
more sensitive than cell culture and sensitivity can be further  increased  by 
bursactomy  (Yuasa et al.,  1988; Hu and Schat, 1993).  
3-2 Detection of CAV antibodies  
3-2-1 Immunoflorescence staining 
                  Viral infection can be demonstrated in chicken tissues by 
immunoflorescence staining (IF), virus tissue impression smear or cryostat 
section fixed with acetone are used for either direct or indirect  IF staining 
employing polyclonal chicken or rabbit hyperimmune serum or monoclonal 
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antibodies to CAV  (McNulty et al.,  1990c; Hoop and Reece, 1991;  Hu and 
Schat,  1993a).   
3-2 -2 Immunoperoxidase  
          This is performed with formalin-fixed paraffin embedded sections 
(McNulty et al., 1991; Smyth et al., 1993). The most satisfactory results are 
obtained with monoclonal antibodies, because polyclonal antibodies may 
produce quite a high level of non  a specific staining background (McNulty et 
al., 1991; Mc Mahon et al., 1996). 
3-3 Serology  
3-3-1 Indirect Florescent Antibodies technique (IFAT)  
           The indirect florescent antibodies technique for the detection of 
antibodies in serum is a standard IFAT (Bulow et al., 1985; Yuasa and Imai, 
1986;   McNulty et al., 1988).    
          Chicken anemia virus infected MSBI or CU 147 cells are used as 
source of antigen, positive and negative reference sera should be included in 
FAT & non infected cells can be used as control. Non specific and background 
staining can be largely reduced by using sufficiently diluted test sera, (i.e:40 or 
1:100) (McNulty et al., 1991).   
3-3-2 Enzyme linked immunosorbent assay ( ELISA)  
               Various commercially available ELISA techniques for the detection 
and measurement of CAV antibodies in chicken sera have been developed, 
these tests are routinely used to screen flocks in countries where vaccines are 
available ( Engstrom, 1999).  But false positive results have been reported 
(Michalski et al., 1996). 
             Antigens generally are prepared from partially purified virus 
preparations grown in MSBI cells, which may include MDV antigen.  
,Recombinant  technology has been used to produce VP3 as a fusion protein 
in bacterial system  (Pallister et al., 1994).  
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          Recently Todd et al. (1999) developed a blocking ELISA using 
monoclonal antibody, 2A9, that react with field isolates from different parts of 
the world and recognize a virus neutralization  epitope  (McNulty et al., 1989a; 
Todd et al., 1999).  The blocking assays has advantages in item of costs 
compared to the indirect assays (Todd et al., 1990b). 
3-3-3 Virus neutralization tests (VN)   
            The VN test was more sensitive than the other two assays (Otaki et 
al., 1991). In VN test serial two - fold dilutions of serum or egg yolk are mixed 
with equal parts of CAV suspension containing 200—500 tissue culture -
infective - doses -50% per0.1ml (Yuasa et al., 1983a; Bulow et al., 1985).  
Qualitative VN tests for flock screening can be made with constant serum 
dilution, lower dilution not recommended because they can be cytotoxic or 
cause virus inhibition, this can be rendered by subcultures in which inoculated 
cells stay live ( Bulow et al., 1985;  Bulow,  1988 ) . 
3-4 DNA based detection of CAV 
3-4-1 Polymerase chain reaction (PCR)   
                PCR assays have become the assay of choice for the detection of 
CAV DNA in infected cell cultures, chicken tissues or vaccines (Noteborn et 
al., 1992b; Soine et al., 1993; Dren et al., 1994; Godwin et al., 1994;   
Rosenberger et al., 1994).  The test proved to be specific and more sensitive 
than cell culture isolation of the virus, very high sensitivity is achieved by 
nested PCR which however,   the  most sensitive for cross contamination 
(Godwin et al., 1993;   Soine et al.,  1993 ). 
3-4-2 Restriction endonuclease mapping ( RE)   
                    In restriction fragment length polymorphism (RFLP) DNA 
segment of interest is cut at specific recognition sites (Dowling et al., 1990). 
The organism may be differentiated by analysis of patterns derived from 
cleavage of their DNA,  sample  DNA is cut with one or more restriction  endo  
nuclease and the resulting fragments separate according to molecular sizes 
using gel electrophoresis, the RE analysis can effectively differentiate the 
17 
 
DNA and amplified DNA fragments of different CAV isolates, all the amplified 
products were digested using Bg II,  Hind  iii and SC1 enzymes (Noteborn et 
al., 1992). 
3-4-3 Nucleotide sequencing   
             Nucleotide difference introducing amino acid changes within the VP3 
with most of the changes in VP1 among the strains which might induce the 
antigenic behavior of different VP (Farkas  et al., 1996: Brown et al.,  2000) 
recorded an overall nucleotide sequence identity of approximately 95% 
indicating close relationship but clear distance as observed by nucleotide 
difference / variability  and amino acid change within the hyper variable 
region.  
3-4-4 DNA probe  
                Detection of CAV in formalin fixed- paraffin embedded thymus 
section by in situ hyperdization  using a biotinylated DNA probe prepared by 
PCR has been described (Allan et al., 1993; Nielsen et al., 1995).           
Biotinylated  DNA probe have been used successfully to rapidly diagnose the 
presence of CIAV in blood smears (Novak and Ragland,  1997;   Sander  et 
al., 1997). 
4- Differential diagnosis   
            Infection criteria have only limited value in diagnosis of CAV, because 
CAV is virtually ubiquitous among chickens, no particular lesions exist that 
can be considered pathognomonic.  Anemia induced by erythroblastosis virus 
can be distinguished from CAV-induced anemia by microscopic examination 
of blood smears.  MDV can cause severe atrophy of the thymus and bursa of 
fabricius especially after infection of very virulent virus (Calnek et al., 1998;   
Miles et al., 2001). IBDV induce atrophy of lymphoid tissue but not affect the 
thymus, MDV and IBDV normally do not cause anemia (Gilka and Spencer, 
1995).  If aplastic anemia occurs it disappears earlier than CAV -induced  
anemia  (Nunoya et al., 1992). 
 
18 
 
5- Control 
5-1 Management procedure  
                Improved hygiene has  reduced  seroconversion  rates,  but this 
may cause problems when flocks get exposed later in life (Mcllory  et al., 
1992;  Jorgensen et al., 1995b;  Engstrom, 1999).  Monitoring of breeder 
flocks for the presence of CAV antibodies should be done to avoid vertically   
transmitted  disease or to test vaccine efficacy ( Cardona et al .,  2000b). 
5-2 Vaccination  
                   Current vaccine strategies are based on the prevention of vertical 
transmission of virus by immunization of breeder flocks and have been 
successful in reducing the incidence of anemia in young chicks (Engstrom, 
1999).  Commercial live vaccines are available in several countries (Bulow,    
1991;   Steenhuisen et al., 1994; Vielitz and Vob, 1994). Vaccination should 
be performed at about 13—15 weeks of age, but never later than 3—4 weeks 
before the first collection of hatching   eggs  to avoid the hazard of vaccine 
virus spread by the egg .Vaccines can be applied in the drinking water or by 
injection in the presence of adjuvants. 
            Recently, an inactivated vaccine was tested in SPF breeder hens, 
vaccinated hens shows seroconversion, and their offspring were protected 
against challenge (Page-Mante, 1997). Unfortunately, the virus titer in MSBI  
cells are generally low (McNulty et al., 1991).  An inactivated  vaccines  may 
not be cost effective for that reason. Although  recombinant vaccines 
expressing VP1 and VP2 are certainly possible (Koch et al., 1994; Noteborn 
et al., 1998a). These have not been licensed to date.  
5-3 Treatment  
            No specific treatment is available for chicken affected by CAV 
infection. Treatment with broad-spectrum antibiotics to control bacterial 
infections usually associated with CIA might be indicated. 
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CHAPTER TWO  
MATERIALS AND METHODS  
2-1 Areas of Study 
                From 20 flocks with different ages of chickens, located in several 
areas in Khartoum state, 450 blood samples were collected from 15th of 
February to 15th of April 2009 (Table, 1).  These flocks were 16 commercial 
layers, 2 commercial broilers and 2 breeder layers. 
               From each flock 5—50 serum samples were collected, none of the 
flocks has had a history of vaccination against CAV of flocks were sampled 
only once and the farms followed an open house system. 
            The blood samples consisted of 340 layers, 75 broilers and 35 breeder 
layers (Table, 2). 
2-2 Collection of blood samples  
                  Blood was collected by veno puncture of the wing vein using 1ml 
and 2ml disposable syringes and direct from the heart in case of day one old 
chickens.  Syringes left in a sloping  position at room temp overnight to allow 
the blood to clot. Serum separated in a labeled Eppendorf  tubes and kept at  
-20o C until tested. 
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Table 1:  The historical correlates of chickens sampled for CAV 
detection 
Location Type of 
chickens 
Age of 
chickens
Size of 
flock 
Breed 
Of 
chicken 
Number of 
samples/% 
Previous 
infections 
Soba 1 Layer 16 wks 10,000 Bovan 10(0.1%)  _  
Soba 2 Layer 72 wks 4000 Hisex 15(0.4%)  IBD 
Soba 3 Layer 16 wks 6000 Hisex 9(0.15%) IBD 
Dekhenat1 Layer 10 wks 2000 Hisex 10(0.5%)  _ 
Kalakla1 Layer 16 wks 3500 Bovan 10(0.3%) IBD 
Kalakla2 Layer 48 wks 500 Bovan 10(2%) _ 
Taiba1 Layer 4 wks 3000 Bovan 26(0.9%) _ 
Droshab1 Layer 40 wks 2000 Hisex 25(1.3%) salmonela
Droshab2 Layer 36 wks 2000 Hisex 10(0.5%) _ 
Hajyossif Layer 36 wks 200 Bovan 50(25%) _ 
Elkabashi Layer 30wks 4ooo Bovan 5(0.12%) _ 
fakihashim Layer 28 wks 3000 Bovan 36(1.2%) _ 
Jablawlia1 Breeder 35 wks 1500 Bovan 16(1.1%) _ 
Soba4 Layer One day 4000 Bovan 19(o.5%) _ 
Jablawlia2 Breeder 60 wks 2000 Bovan 19(0.9%) _ 
Merkhiat Layer 102wks 3000 Hisex 52(1.7%) _ 
Taiba2 Layer One day 6000 Bovan 15(0.3%) _ 
Alsagi Broiler 4 wks 500 Habard 23(4.6%) _ 
Dekhenat2 Broiler 6wks 3000 Lohmn 52(1.7%) _ 
Soba5 Layer 16 wks 7500 Bovan 38(0.5%) ND 
 
*IBD: Infectious Bursal Disease             *ND Newcastel Disease 
_ No   infection 
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Table 2: Distribution of collected sera by chicken type 
Type of chickens Number of samples collected 
 
Layer 340 
 
Broiler 75 
 
Breeder layer 35 
 
 
2-3 Enzyme linked immunosorbent assay (ELISA)  
          A commercial test kit of CAV was used to detect specific antibodies 
against CAV, based on indirect  ELISA,  the kit was obtained from Pro flock 
Plus SYNBIOICS Corporation in USA. 
        A serum dilution of 1:50 dilution was used following the instruction of the 
manufacturer and optical density value was read using an ELISA plate reader 
at 405 nm wave length. 
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2-3-1 Materials and Reagents provided with the kit    
(1)  CAV antigen coated microtiter plates (inactivated viral antigen).  
(2)  CAV positive control  serum. 
(3)  CAV negative control serum. 
(4)  Goat-anti-chicken- IgG  (H+L)  peroxidase  conjugate solution.  
(5)  ABTS -  hydrogen peroxidase  substrate  solution.  
(6)  Dilution Buffer.  
(7) Wash solution.  
(8) Stop solution.  
2-3-2 Equipments and materials required in the test  
(1) High precision single  microtiter  pipette volume (0.01ml).  
(2)  8 or 12 channels microtiter pipette and disposable tips volume (0.15 ml).  
(3)  Two graduated cylinders 50ml.  
(4) Two clean glass tubes.  
(5) Laboratory grade water.  
(6)  96 well uncoated microtiter plate for serum dilution (serum dilution plate)  
(7)  Plate reading spectrophotometer with 405nm filter.  
(8)  Microtiter  plate washing apparatus.  
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2-3-3 Sample preparation 
               Serum samples were diluted using dilution buffer in a clean un 
coated 96 microtiter plate, frozen serum completely thawed and mixed 
thoroughly before diluting, each serum sample was diluted 1:50.  
(1)  Positive and negative controls wells were labeled  corospondinge  to the 
CAV coated plate.  
(2)  0.3 ml dilution buffer were added to each well of dilution plate except the 
wells of positive and negative control. 
(3)  0.006 ml of un known serum were added per well using asingle microtiter 
pipette, each tip was discarded after each sample. 
(4) All diluent serum was allowed to equilibrate in dilution buffer for 5min 
before transferring to a CAV antigen coated plate. 
2-3-4 Reagents preparation           
             All reagents were allowed to come to room temp (22oC—24oC) before 
used. 
2-3-4-1 Preparation of positive and negative controls 
               Apropriate volume  (0.006ml) of CAV positive and negative controls 
were diluted with dilution buffer (0.3ml) in a clean glass test tube making 1:50 
dilution and mixed well, the same was done for negative control.  
2-3-4-2 Preparation of washing solution     
               Fifteen ml concentrated washing solution were diluted in 285 ml 
laboratory grade water (1:20) making 300ml solution for each CAV microtiter 
ELISA plate. 
2-3-4-3 Preparation of conjugate solution      
0.1 ml   stock conjugate were added in 10 ml dilution buffer (1:100), this 
preparation was used for one 96 well ELISA  microtiter plate.  
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 2-3-4-4 Preparation of substrate solution  
 10 ml was added for each plate without dilution  
2-3-4-5 Preparation of stop solution  
2.5 ml concentrated stop solution were diluted in 10 ml laboratory grade water 
(1:5) for each CAV coated plate. 
2-3-5 Test Procedure    
(1)  A CAV antigen coated test plate was removed from the protective sealed 
bag and placed on the clean bench, positive and negative control wells were 
labeled. 
(2)  0.05 ml dilution buffer were added to all wells on the CAV test plate using 
12 channels microtiter pipette. 
(3) 0.05 ml diluted serum samples from each well in the dilution plate were 
taken using 8 or 12 channels microtiter pipette and added to the CAV coated 
micro-titer plate yielding 1:100 dilution, except  wells of positive and negative 
control. Tips were discarded after each raw of diluted samples transferred. 
(4) 0.05 ml CAV diluted  positive control serum were added to the A1, A3, 
wells, pipette tip was discarded and  0.05 diluted negative control  serum were 
added to A2, H10 and H12 wells. 
(5)  Tested  plate was covered by a lid and incubated for 30 min at room temp 
(22oC—24oC). 
(6)  Plate was allowed to automatic wash for about 3 times, non specific 
antibodies and other serum proteins were washed away, this was take 9mins. 
(7)  Plate was inverted and tapped firmly in absorbent paper, to ensure all 
liquid was removed. 
(8)  o.1 ml of prepared anti - chicken – IgG-Peroxidase conjugate solution 
were added to the test micro titer plate using  12 channels microtiter pipette. 
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(9)  Plate was covered with lid and incubated for 30min at room temp (22oC—
24oC). 
(10)  Plate was allowed to automatic wash. 
(11)  Plate was inverted and tapped firmly on absorbent paper to ensure all 
liquid was removed.  
(12)  0.1 ml substrate solution were added to each well of tested plate, using 
12 channels microtiter pipette. 
(13) Tested plate was covered with a lid and incubated for 15 min at room 
temp (22oC—24oC). 
(14) 0.1 ml diluted stop solution to each well of the tested plate using 12 
channels microtiter pipette to stop the reaction. 
(15)  Light green color was developed in positive wells. 
(16)  Microtiter plate reader was blanked and the plate was put in the reader, 
absorbance of control and samples were recorded by reading at 405 nm. 
2-3-6 Interpretation of results 
                Valid CAV ELISA results were obtained when the average (O.D) 
value of the negative control serum was less than 0.2 and the corrected 
positive control value range was obtained between (0.25—0.9). The CAV 
ELISA titer values obtained was represent a comparison of the CAV 
antibodies within each field chicken serum tested and the CAV ELISA kit 
positive and negative control sera. 
                A "0" CAV ELISA titer represent a chicken serum  samples that 
contains extremely low to insignificance CAV antibody level compared to CAV 
ELISA kit positive and negative control sera. CAV ELISA titer obtained above 
"0" indicate that chicken serum samples contains ELISA detectable CAV 
antibody level compared to positive and  negative control sera. 
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2-3-7 Manual processing of data           
(1)  Calculation of Antibody Titer: 
CAV ELISA titer can be calculated using the following equation: 
LOG 10 TITER = 1.01*LOG 10 (SP) + 3.62 
TITER=ANTILOG OF LOG 10 TITER 
(2 ) Calculation of S/P ratio: 
Mean of test sample absorbance - Mean of negative control 
___________________________________________________ 
Mean of positive control – Mean of negative control 
• S/P (Sample to positive ratio)   
 
S/P value 
Titer Range Antibody status 
0.4 or less 1469 or less Negative 
0.5 or greater  1470 or more Positive 
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CHAPTER THREE 
RESULTS 
 Prevalence of antibodies against CAV  
                  Out of 450 serum samples collected from a total of 20 commercial 
chicken flocks, 397 (88.2%) were found positive while 53 (11.8 %) were 
negative ( Table 3 ). The prevalence of antibodies was shown in Figure: (1).   
                      In 16 commercial layers flocks, 311 (91.5%) were positive out of 
340 serum samples &29 (8.5%) were found negative (Table 4), Prevalence of 
antibodies against CAV in these flocks was shown in Figure: (2). 
            In 2 commercial broilers  flocks  evaluated, out of 75 serum samples 
collected, 52 (69.3%) were found positive and 23 (30.7%) showed negative 
result (Table 5), Figure: (3) showed the prevalence of antibodies against CAV 
in these flocks.   
              Examination of 35 serum samples taken from 2 layer breeding flocks, 
showed 34 ( 97.1%) positive samples while, 1 (2.9%) was negative (Table 6), 
this high prevalence of antibodies against CAV was shown in Figure: (4). 
               Prevalence of antibodies against CAV in collected sera was 
recorded according to the age of chicken flocks (Table 7), this is showen in 
Figure: (5). 
             Different breeds of chicken flocks were evaluated for detection of 
antibodies against CAV, prevalence of antibodies was recorded (Table, 8), 
Figure: 6 showes these results. 
        The clinical symptoms observed were depression,  ruffeled feather, 
hemorrhagic dermatitis(Figure: 10),  pale comb and wattle and dullness 
(Figure:11). 
  Postmortem examinations revealed several PM lesions, these lesions 
include enlarged pale liver (Figure, 8), congested viscera (Figure: 9) and 
anemic carcass. 
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Table3:   Prevalence of antibodies against CAV in sera collected from 
chicken in Khartoum state: 
Number of samples Positive (%) Negative (%) 
 
450 397 (88.2%) 53 (11.8%) 
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Table 4:   Prevalence of antibodies against CAV in sera collected from 
layers in Khartoum state: 
Location of farm  Number of 
samples 
Positive (%) Negative (%) 
Soba1 10 10 (100%) 0 (0 %) 
Soba2 15  15 (100%) 0 (0%) 
Soba3 9 9 (100 %) 0 (0 %) 
Dekheenat1 10 10 (100%) 0(0%) 
Kalakla1 10 10 (100%) 0(0%) 
Kalakla2 10 10 (100%) 0 (0%) 
Taiba1 26 4 (15.4%) 22 (84.6%) 
Droshab1 25 24 (96%) 1 (4%) 
Droshab2 10 9 (90%) 1 (10%) 
Hajyossif 50 50 (100%) 0 (0%) 
Elkabashi 5 5 (100%) 0 (0%) 
Alfaki hashim 36 36 (100%) 0 (0%) 
Soba4 19 15 (78.9%) 4 (21.1%) 
Markhiat 52 52 (100%) 0 (0%) 
Taiba2 15 15 (100%) 0 (0%) 
Soba5 38 37 (97.4%) 1 (2.6%) 
Total 340 311 (91.5%) 29 (8.5%) 
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Table 5:  Prevalence of antibodies against CAV in sera collected from 
broilers in Khartoum state: 
Location of farm 
 
Numbers of 
samples 
Positive (%) Negative (%) 
Dekheenat2 52  52 (100%) 0 (0%) 
 
Alsagay 
 
23 0 (0%) 10023 (%) 
Total 
 
75 52 (69.3%) 23 (30.7%) 
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Table 6:  Prevalence of antibodies against CAV in sera collected from 
breeder layers in Khartoum state: 
Location of farm Number of 
samples 
 
Positive (%) Negative (%) 
Jabal awlia 1  
16 
16 (100%) 0 (0%) 
Jabal awlia2 19 
 
18 (94.7%) 1 (5.3%) 
Total  
35 
34 (97.1%) 1 (2.9% )  
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Table 7:  Prevalence of antibodies against CAV in sera collected by age: 
Age of chicken Number of 
samples 
Positive (%) Negative (%) 
Day one old 34 30 (88.2%) 4 (11.8%) 
4 weeks 49 4 (8.2%) 45 (91.8%) 
 6 weeks 52 52 (100%) 0 (0%) 
 10 weeks 10 10 (100%) 0 (0%) 
16 week 67 66 (98.5%) 1 (1.5%) 
30 week 41 41 (100%) 0 (0%) 
36 week 76 75 (98.7%)  1 (1.3%) 
40 week 25 24 (96%)  1 (4%) 
48 week 10 10 (100%) 0 (0%) 
60 week 19 18 (94.7%) 1 (5.3%) 
72 week 15 15 (100%) 0 (0%) 
102 week 52 52 (100%) 0 (0%) 
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Table 8:  Prevalence of antibodies against CAV in collected sera by type 
of breed: 
Breed Number of 
samples 
Positive (%) Negative (%) 
Bovan 254 226 (89%) 28 (11%) 
Hisex 121 119 (98.3%) 2 (1.7%) 
Habard 23 0 (0%) 23 (100%) 
Lohman 52 52 (100%) 0 (0%) 
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Figure : (1) Seroprevalence of antibodies against CAV in different 
chicken flocks in Khartoum state 
  
 
Figure: (2)  Sero prevalence of antibodies against CAV in commercial 
layers in Khartoum state  
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Figure : (3) Seroprevalence of antibodies in broiler chicken in Khartoum 
state  
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Figure: (4) Seroprevalence of antibodies against CAV in breeder layers 
in Khartoum state 
  
 
 
Figure: (5) Seroprevalence of antibodies against CAV in different age groups 
of chicken in Khartoum state 
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Figure: (6) Seroprevalence of antibodies against CAV in different breeds in 
Khartoum state 
 
 
 
  
Figure: (7) CAV ELISA micro titer plate show positive serum samples. 
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Figure: (8) The arrow shows enlarged pale liver of CAV infected 
chicken 
 
 
 
 
 
 
 
 
 
Figure: (9) The arrow shows congested viscera and subcutaneous 
hemorrhage of CAV infected chicken 
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Figure: (10)  The arrow shows hemorrhagic dermatitis of CAV 
infected chicken 
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Figure: (11) The arrow shows pale comb and wattle and dullness of CAV 
infected chicken  
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CHAPTER FOUR 
DISCUSSION 
                 Infections with CAV are considered economically significant. The 
disease is manifested with either visible or invisible clinical signs. In young 
chicks of less than 3 weeks without CAV maternal antibodies, the infection 
expressed by stunting growth, increased mortality, anemia, sub cutaneous 
hemorrhage and decreased resistance to secondary infections (Markoski and 
Schat, 2003). 
                Through the investigation of different chicken flocks in different 
farms in Khartoum state, gross pathological lesions of pale comb and wattle, 
subcutaneous hemorrhage, congested viscera and pale liver were   
suggestive of CIA disease, therefore, the need was felt to go for monitoring 
the incidence of the disease in the state in order to determine the importance 
of CIA in Sudan and help plan a suitable control strategy against this 
economically important emerging avian pathogen. 
                 Keeping the above points in consideration, the present study was 
undertaken to verify the degree of spread of CAV to the chicken flocks of 
different types and age. This was accomplished by measuring the titer of CAV 
antibodies in different commercial poultry farms distributed in different areas in 
Khartoum state in order to a certain the presence of CAV infection in Sudan 
and to determine the prevalence rates of the disease. 
               These determinations based on serological investigation, were made 
by indirect ELISA. The epidemiological procedure performed using computer 
design, specific design for analysis, producing data that can be considered 
representative of the actual field situation in these commercial chicken flocks. 
           In the present study, 450 serum samples from different chicken flocks 
in Khartoum state were tested by indirect ELISA, (340 commercial  layers, 75 
broilers and 35 breeder layers), the results obtained from this study revealed 
highest prevalence of CAV antibodies in breeder layer flocks (97.1%), 
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followed by commercial layer flocks (91.5%) and then broiler flocks with 
(69.3%), these results were agreed with Ballal et al.(2005),  who detected 
seroprevalence in breeders, layers and broilers, 100%, 67.3% and 44.3%  
respectively through a serological survey in different  commercial chicken 
flocks  in Khartoum state. 
                    Since there is no history of vaccination program against CAV in 
Sudan,  presence of high prevalence of antibodies in day one old chicks in 
this study (88.2%) are due to presence of maternal antibodies. This is 
interesting since chicks from such breeders are probably protected during 
their first week of life by maternally derived antibodies (MDAs). This had 
recently confirmed by Dergham, (2006) from Jordan and Otaki et al (1987) 
who showed that maternal antibodies   against the infection of CAV are highly 
protective during the first week of the chick life. 
            In this study, the prevalence of antibodies in different age groups was 
evaluated. The results obtained showed variations in prevalence of antibodies 
in different age group studied. These variations indicated that no relationship 
between the age and mean titer of antibody were observed. It was noted that 
CAV is ubiquitous and infects all poultry flocks at any age. Similar findings 
were reported by Barenteno et al. (2000), De Herdet et al.(2000) and 
Dergham (2006).  Claudio et al. (2004) also found that no significant 
difference between breeding periods. 
              In this study high prevalence of antibodies in sera collected from 
different chicken flocks, with different locations, types, ages and breed 
indicates the continuous field challenge of CAV.  
             Chicken anemia virus (CAV) acts synergically with IBVD and other 
immunosuppressive diseases, when the history of the tested flocks was 
evaluated. We also found that the history of some of CAV positive flocks had 
also showed other viral infections such as IBDV and ND beside some 
bacterial diseases such as salmonellosis. However we cannot judge which 
infection predispose to the other as all these infections are 
immunosuppressive. Again, this will need cotiniuous investigations and study 
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of these pathogens in the field. This had been reported by Rosenberger and 
Cloud, (1989b), Otaki et al. (1992) and Miles et al. (2001). 
                  When the age of chicken were taken into account, from 
commercial layers and broilers, the occurance of CAV with a history of 
previous infection with IBD, in spite of vaccination, or some bacterial infections 
may explained by possible immunosuppression caused by CIA prior to IBD or 
bacterial infection ( Huseyin et al., 2008) . 
                Postmortem examinations performed indicated the alarming 
situation in the field with regard to CAV incidence in Khartoum state. These 
postmortem lesions recorded were characteristic of CAV infection, involving 
muscular and visceral hemorrhage as well as enlarged pale liver.  With regard 
to clinical symptoms, these include dullness, ruffeled feather, hemorrhagic 
dermatitis, and pale comb and wattle. These lesions and signs were reported 
in some chicken flocks which revealed high prevalence of antibodies against 
CAV when examined by ELISA.  Similar symptoms and lesions have also 
been reported by Yuasa et al. (1989), Lucio et al. (1990), Pope (1991), Toro et 
al.(2000),  Hagood (2000) and Davidson et al.(2004). These typical signs and 
lesions   produced by CAV indicated the pathogenic potential and the immuno 
suppressive nature of the virus which supported the reports of other 
researchers (McNulty, 1991; Bulow and Schat, 1997; Dhama, 2002; 
Senthkumer, 2004). 
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Conclusion 
                            Results obtained from this study implies the following,  
1. Overall chickens with different types in different locations show high 
prevalence of anti bodies against CAV. 
2. No variations were noted in age susceptibility to CAV.  
3. Results of this study showed that CAV infection in poultry farms in 
Khartoum state is more common   than expected and is another one of the 
important causes of immune suppression in chicken flocks. 
Recommendations:  
 1. Histopathological examinations are so necessary for further clinical 
investigation of chicken anemia virus especially for negatives diagnosed 
serum samples to see  the virus shedding.    
2. Further studied are necessary, using a developed techniques such as 
molecular diagnosis. This can assess the economic losses due to CIA and the 
cost benefit of the control measures. 
 3. We strongly recommended using vaccine against CAV in the routine 
vaccination schedules in Sudan, especially in Parent flocks country wide. The 
vaccination may prevent further virus spread and can also minimize vertical 
transmission of virus in field condition. 
4. Farmers need to be instructed about the signs and importance of CIA.   
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